CompletedNCT01394601
Real-World Antipsychotic Use During Acute Schizophrenia Care
About this title
A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia
Read the official source — NCT01394601Observational studyAges 18+Russia
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Chita and 7 more locationsSee all locations and recruitment
Study information
Study start dateAugust 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 600
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Russia
- Age range
- Over 18 Years
- Official registry ID
- NCT01394601
- Official title
Show the full official title
RECONNECT-S ALPHA: A Non-interventional Study to Observe Real-life Allocation of Antipsychotics in the Acute Inpatient Management of Schizophrenia
Get this study by email
Recruitment & locations
CompletedChita, Russia · Ivanovo, Russia · Krasnodar, Russia
6 more locations
- Moscow, Russia
- Novosibirsk, Russia
- S-Petersburg, Russia
- Samara, Russia
- Yekaterinburg, Russia
- Russia
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
Listed age limits: from 18 years.
